Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024

newsfile17:20 ET

Express News | Adaptimmune Therapeutics: Entered Mutual Release and Resolution Agreement With Genentech Inc & F. Hoffmann-La Roche Ltd

ReutersSep 23 16:43 ET

Adaptimmune to Participate in Two Bank Conferences This September

newsfileAug 28 08:00 ET

Individual Investors Who Own 39% Along With Institutions Invested in Adaptimmune Therapeutics Plc (NASDAQ:ADAP) Saw Increase in Their Holdings Value Last Week

Simply Wall StAug 27 08:39 ET

European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading

MT NewswiresAug 26 11:25 ET

European Equities Traded in the US as American Depositary Receipts Trend Slightly Higher in Wednesday Trading

MT NewswiresAug 21 11:22 ET